Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.

Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M.

Cancer. 1996 Oct 15;78(8):1762-74.

3.
4.

PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.

Inagaki T, Ebisuno S, Uekado Y, Hirano A, Hiroi A, Shinka T, Ohkawa T.

Int J Urol. 1997 Mar;4(2):172-7.

5.

p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.

Skopelitou A, Hadjiyannakis M, Dimopoulos D, Kamina S, Krikoni O, Alexopoulou V, Rigas C, Agnantis NJ.

Eur Urol. 1997;31(4):464-71.

PMID:
9187909
6.

Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.

Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.

Anticancer Res. 2000 Jan-Feb;20(1B):505-10.

PMID:
10769714
7.

Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.

Micozkadioğlu D, Unal M, Pata YS, Baştürk M, Cinel L.

Med Sci Monit. 2008 Jun;14(6):CR299-304.

PMID:
18509272
8.

[Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].

Yoshikawa H, Ikeuchi T, Iguchi H, Onodera Y, Kai Y.

Hinyokika Kiyo. 1995 Apr;41(4):253-8. Japanese.

9.
10.

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10.

PMID:
11286838
11.

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP.

Jpn J Clin Oncol. 2003 Apr;33(4):173-9.

PMID:
12810831
12.
13.

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.

Shiina H, Igawa M, Urakami S, Honda S, Shirakawa H, Ishibe T.

J Clin Pathol. 1996 May;49(5):395-9.

14.

Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.

Pich A, Margaria E, Chiusa L, Bortolin P, Palestro G.

Oncol Rep. 2003 Sep-Oct;10(5):1329-35.

PMID:
12883702
15.

Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.

Korkolopoulou P, Angelopoulou MK, Kontopidou F, Tsengas A, Patsouris E, Kittas C, Pangalis GA.

Leuk Lymphoma. 1998 Aug;30(5-6):625-36.

PMID:
9711925
17.
18.

p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer.

Moch H, Sauter G, Mihatsch MJ, Gudat F, Epper R, Waldman FM.

Hum Pathol. 1994 Dec;25(12):1346-51.

PMID:
8001930
19.

Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.

Ajiki T, Kamigaki T, Hasegawa Y, Fujino Y, Suzuki Y, Takeyama Y, Ku Y, Kuroda Y.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1266-70.

PMID:
11677943

Supplemental Content

Support Center